Research published in Cell on 29th August by the groups of Filipe
Cabreiro from the MRC London Institute of Medical Sciences and
Imperial College and Christoph Kaleta from Kiel University in
Germany has demonstrated that diet can alter the effectiveness
of a type-2 diabetes drug via its action on gut bacteria.
A Kiel-based research team has been able to show that changes in
the composition of intestinal bacteria in those with type 2 diabetes
is linked more to being overweight and taking supplements or
medication, and less to diabetes itself.